Essence Pharmaceuticals: A subsidiary leads the formulation of industry standards for products.

Essence Pharmaceutical Announcement: Recently, the industry standard for "13-dioctyl cyclohexane" led by the company's subsidiary Shandong Luhua Senxuan New Material Co., Ltd. has passed the review of the national standardization committee and been announced by the Ministry of Industry and Information Technology of the People's Republic of China. The standard will be officially implemented starting from March 1, 2026.